# of Displayed Technologies: 1 / 1


Predicting TKI Efficacy in Cancer Through a Single-Cell-Guided Model of Kinase Activation
TS-005733 — A computational system for prioritizing tyrosine kinase inhibitors (TKIs) by integrating single‑cell transcriptional data, advanced computational modeling, and machine‑learning–based scoring to identify tumor‑specific signaling vulnerabilities across the entire tumor microenvironment.
  • College:
  • Inventors: Cannon, Matthew; Roberts, Ryan
  • Licensing Officer: Corris, Andrew

Loading icon